GlaxoSmithKline

Company Overview
Company Details
Company News
23andMe Kit / Image: Getty
23andMe and GSK Are Using DNA to Develop New Drugs
Jul 29th, 2019
Pharma Brexit / Image: Cath Levett
Brexit Contingency Plans for Pharma Industry
Feb 28th, 2019
TB Vaccine / Image: iStockphoto
New Vaccine Fights Latent TB Infections
Oct 3rd, 2018
23andMe Genetic Test / Image: 23andMe
GSK Teams Up With 23andMe to Develop Drugs
Aug 3rd, 2018
GSK Facility in London / Image: Maxwell Hamilton
GSK Recalls 600,000 Ventolin Inhalers
Apr 14th, 2017
More from GlaxoSmithKline
23andMe Kit / Image: Getty
23andMe and GSK Are Using DNA to Develop New Drugs
A partnership between the two companies has yielded six potential new drugs, but using customers’ genetic information to do so raises ethical questions.
Jul 29th, 2019
Pharma Brexit / Image: Cath Levett
Brexit Contingency Plans for Pharma Industry
The EU currently supplies two-thirds of the medicines in the UK. How will Brexit affect pharmaceutical investments and manufacturing?
Feb 28th, 2019
TB Vaccine / Image: iStockphoto
New Vaccine Fights Latent TB Infections
GlaxoSmithKline has developed a tuberculosis vaccine that could prevent the development of the bacterial disease in half of the recipients.
Oct 3rd, 2018
23andMe Genetic Test / Image: 23andMe
GSK Teams Up With 23andMe to Develop Drugs
GlaxoSmithKline has signed an agreement with home DNA test company 23andMe to collaborate on drug development.
Aug 3rd, 2018
GSK Facility in London / Image: Maxwell Hamilton
GSK Recalls 600,000 Ventolin Inhalers
A manufacturing glitch at GSK’s North Carolina facility caused Ventolin inhalers to be made with a defective delivery system.
Apr 14th, 2017
FDA commissioner nominee, Scott Gottlieb
Get to Know Trump’s FDA Pick
President Trump’s nominee for FDA commissioner, Scott Gottlieb, could help speed up regulatory approval of drugs.
Mar 21st, 2017
Nucala Box / Image: GSK
NICE Endorses GSK’s Asthma Biologic
GlaxoSmithKline’s biologic for severe refractory eosinophilic asthma receives approval from cost regulators.
Feb 2nd, 2017
Zeasorb
GSK Label Mistakes Athlete’s Foot with Jock Itch
Labeling issues stating “use for the cure of most jock itch' rather than 'use for the cure of most athlete's foot' leads to massive recall.
Dec 16th, 2016
GSK Workshop Announced at E&L Europe 2015
Smithers Rapra will be partnering with GSK to provide an intermediate workshop exploring risk-based approaches in E&L.
Aug 24th, 2015